Stocks
Deciphera Pharmaceuticals (DCPH) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.06 | 1.97 | 0.86 | 1.73 | 1.34 | 1.27 | |||
| Changes by years, y/y, % | +9% | -36% | -56% | +102% | -22% | -13.8% | |||
Deciphera Pharmaceuticals. Debt/EBITDA
Deciphera Pharmaceuticals. Debt/EBITDA, changes, %
Deciphera Pharmaceuticals (DCPH) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q1 | FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | LTM ? | |||
| Debt/EBITDA | 2.08 | 1.60 | 1.55 | 1.39 | 1.27 | 1.27 | ||
| Changes by years, y/y, % | +160% | +15% | +0% | -19% | -39% | |||
| Changes by quarters, q/q, % | +21% | -23% | -3% | -10% | -9% | |||
